论文部分内容阅读
目的:观察氨溴索治疗小儿支气管肺炎的临床效果。方法:选取我院收治的120例支气管肺炎患儿,随机平均分为A、B两组。给予A组患者常规治疗,在常规治疗基础之上,给予B组患者氨溴索治疗,对两组患者临床治疗效果进行分析。结果:A组患者治疗总有效率为73.3%,B组患者治疗总有效率为93.4%。两组对比,B组患者治疗效果更为优越,差异显著具有统计学意义(P<0.05)。A、B两组患者在咳嗽缓解时间、肺部湿罗音消失时间、住院时间等方面进行对比,B组患者更具优越性。两组对比差异显著具有统计学意义(P<0.05)。A组患者不良反应发生率为8.3%,B组患者不良反应发生率为10.0%。两组对比差异差异不具有统计学意义(P>0.05)。结论:氨溴索治疗小儿支气管肺炎效果显著,值得临床推广。
Objective: To observe the clinical effect of ambroxol on bronchial pneumonia in children. Methods: A total of 120 children with bronchopneumonia admitted in our hospital were randomly divided into A and B groups. A group of patients given conventional treatment, based on conventional treatment, given ambroxol B group patients, the clinical efficacy of the two groups were analyzed. Results: The total effective rate of treatment in group A was 73.3% and that in group B was 93.4%. The two groups were compared, the treatment effect of group B was more superior, the difference was statistically significant (P <0.05). A, B two groups of patients in the cough relief time, lung wet rales disappear time, hospital stay and other aspects of comparison, B group of patients with more superiority. The difference between the two groups was statistically significant (P <0.05). The incidence of adverse reactions in group A was 8.3%, and that in group B was 10.0%. The differences between the two groups were not statistically significant (P> 0.05). Conclusion: Ambroxol treatment of bronchial pneumonia in children with significant effect, worthy of clinical promotion.